ROFLUMILAST

Roflumilast is a PDE4 inhibitor used in severe COPD to reduce inflammation and exacerbations. Side effects include weight loss, diarrhea, nausea, insomnia, anxiety, and headache. Only GMP materials will be supplied, logistics all according to GDP.

SKU: f7e6795a7585 Category: Tag:

Product Description


Mechanism of Action

ROFLUMILAST engages in multilayer biochemical interactions affecting enzyme cascades, receptorregulated signalling, oxidativestress systems, mitochondrial respiration, ionchannel dynamics, cytoskeletal mechanics and transcriptionfactor pathway coordination. Molecularmodelling parameters suggest potential interactions with catalytic centres, allosteric microdomains, transmembrane receptor helices, cofactorbinding regions, and structural scaffolding proteins. These interactions enable modulation of phosphorylation cycles, secondmessenger amplification (Ca²⁺, cAMP, IP, DAG), ATP turnover, mitochondrial membrane potential and ROS balancing capacity.

Benefits and Applications

  • Receptorligand affinity mapping and molecular docking
  • Enzymekinetic pathway modelling and catalyticflux analysis
  • Mitochondrial bioenergetics profiling and redoxstate research
  • Multiomics studies (transcriptomics, metabolomics, proteomics)
  • Cytoskeletal architecture analysis and membranedynamics modelling
  • Apoptosis, necroptosis, autophagy and ferroptosis pathway assays
  • SAR and QSARdriven molecular optimisation
  • Pharmacodynamic and mechanistic doseresponse modelling

Risks & Side Effects

  • Oxidative imbalance and ROS escalation
  • Mitochondrial overload or suppression of respiratory complexes
  • Ionchannel destabilisation (Na⁺/K⁺/Ca²⁺)
  • Unintended receptor crosstalk
  • Cytoskeletal destabilisation
  • Dosedependent cytotoxicity or programmed-cell-death activation
  • Inflammatory transcriptional activation (NF-κB, JNK, MAPK)

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C17H14Cl2FNO3

Molecular Weight

403.2 g/mol

CAS Number

162401-32-3

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Sparingly soluble

Purity

Purity information is available upon request (COA).

Synonym

Roflumilast; 162401-32-3; DAXAS; 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE; Daliresp

IUPAC/Chemical Name

3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide

InChl Key

MNDBXUUTURYVHR-UHFFFAOYSA-N

InChl Code

InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)

References

https://pubchem.ncbi.nlm.nih.gov/compound/449193;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download